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Abstract: High-throughput proteomics experiments in-
volving tandem mass spectrometry produce large vol-
umes of complex data that require sophisticated compu-
tational analyses. As such, the field offers many challenges
for computational biologists. In this article, we briefly
introduce some of the core computational and statistical
problems in the field and then describe a variety of
outstanding problems that readers of PLoS Computational
Biology might be able to help solve.
This is an ‘‘Editors’ Outlook’’ article for PLoS Computational
Biology
Introduction
DNA gets a lot of attention these days, in whole genome
sequencing projects, genome-wide association studies, and exper-
iments measuring transcription factor binding, chromatin acces-
sibility, DNA methylation, and histone modification profiles. But
proteins are the molecular workhorses of the cell, and proteo-
mics—the systematic study of the complete set of proteins
expressed in a given cell, tissue, or organism—is poised to become
the next hot topic.
Just as next-generation sequencing tehcnology is driving the
current genomics boom, so improvements in tandem mass
spectrometry technology are leading to more comprehensive and
precise proteomics assays. Like a short-read sequencing machine,
a mass spectrometer runs 24 hours a day, producing a huge
quantity of data. And like short-read sequencing data, mass
spectral data sets exhibit complex dependencies and patterns of
missing data. In both fields, the underlying technologies, along
with the characteristics of the resulting data sets, change rapidly,
requiring constant development of new analytical methods.
Strikingly, however, relatively few bioinformatics researchers
work on methods for analyzing mass spectrometry data. PLoS
Computational Biology published only two papers on the topic in
2010 [1,2]. At the Intelligent Systems for Molecular Biology
(ISMB) conference, none of the designated subject areas for
submitted manuscripts is relevant to mass spectrometry analysis,
and over the last three years, a total of four mass spectometry
papers were published at ISMB, each appearing in the ‘‘Other
bioinformatics applications’’ category. Meanwhile, the annual
American Society for Mass Spectrometry conference draws more
than 6,000 attendees, and the society boasts 7,000 current
members.
Some of the forces preventing people from entering the mass
spectrometry research arena are social. As a field, mass
spectrometry is older than genomics, and as such, the norms
around the sharing of mass spectrometry data are less open. In
addition, intellectual property issues, such as the SEQUEST
patents held by the University of Washington, may have
discouraged some researchers from entering the field.
An equally important impediment, however, is the ‘‘energy
barrier’’ associated with starting out in mass spectrometry. In the
late 1990s, microarray analysis took off with surprising rapidity, in
part because the data could be fairly accurately summarized in
matrix format, and manipulating matrices is familiar to computer
scientistics, electrical engineers, and physicists. This is not the case
with mass spectrometry data. If you show someone with no
relevant background knowledge a DNA sequence or a microarray
image, explaining what they are looking at will take less time than
explaining to that same person what a peptide fragmentation
spectrum is.
The goal of this article is to lower that energy barrier by
explaining in simple terms how a tandem mass spectrometry
experiment works and what are the key research problems
associated with this type of data.
A Typical Shotgun Proteomics Experiment
A typical shotgun proteomics experiment proceeds in three
steps, as illustrated in Figure 1A. The input to the experiment is a
collection of proteins, which have been isolated from a complex
mixture. A typical complex mixture may contain a few thousand
proteins, ranging in abundance from tens of copies to hundreds of
thousands of copies.
In the first experimental step, the proteins are digested into
peptides using a protease. This digestion is necessary because
whole proteins are too massive to be subject to direct mass
spectometry analysis without using very expensive equipment.
Second, the peptides are subjected to liquid chromatography, in
which the peptides pass through a thin glass column that separates
the peptides based on a particular chemical property (e.g., the
hydrophobicity). This separation step reduces the complexity of
the mixtures of peptides going into the mass spectrometer. The
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rounds of mass spectrometry. Approximately every second, the
device analyzes the population of *20,000 intact peptides that
most recently exited from the liquid chromatography column.
Then, based on this initial analysis, the machine selects
approximately five distinct peptide species for fragmentation.
Each of these fragmented species is isolated and subjected to a
second round of mass spectrometry analysis. The resulting
‘‘fragmentation spectra’’ are the primary output of the experiment.
A sample fragmentation spectrum is shown in Figure 1B.
During the fragmentation process, each amino acid sequence is
typically cleaved once, so cleavage of the population results in a
variety of observed prefix and suffix sequences. Each of these
subpeptides is characterized by its mass-to-charge ratio (m/z,
shown on the horizontal axis) and a corresponding intensity
(unitless, shown on the vertical axis). The primary analysis
challenge is to infer, for each observed fragmentation spectrum,
the peptide sequence that was responsible for generating the
spectrum.
Peptide and Protein Identification
The Spectrum Identification Problem
The spectrum identification problem is difficult to solve
primarily because of noise in the observed spectrum. In general,
the x-axis of the observed spectrum is known with relatively high
precision. However, in any given spectrum, many expected
fragment ions will fail to be observed, and the spectrum is also
likely to contain a variety of additional, unexplained peaks. These
unexplained peaks may result from unusual fragmentation events,
in which small molecular groups are shed from the peptide during
fragmentation, or from contaminating molecules (peptides or other
small molecules) that are present in the mass spectrometer along
with the target peptide species.
In practice, solutions to the spectrum identification problem fall
into four general categories. By far the most commonly used
approach is database search. The first computer program to use a
database search procedure to identify fragmentation spectra was
SEQUEST [3], and SEQUEST’s basic algorithm (not including the
function used to score individual peptide-spectrum matches) is still
used by essentially all database search tools available today. The
approach is as follows. Weare given a spectrum S, a peptide database
P, a precursor mass m (i.e., the observed mass of the intact peptide),
and a user-specified precursor mass tolerance d.T h ea l g o r i t h m
extracts from the database all peptides whose mass lies within the
range ½m{d,mzd . These comprise the set of candidate peptides
C(m,P,d)~fp : p [ P;jm(p){mjvdg
wherem(p)isthe calculated massofpeptidep.Inpractice,depending
on the size of the peptide database and the precursor mass tolerance,
the number of candidate peptides ranges from hundreds to hundreds
of thousands. Each candidate peptide p is compared to the observed
spectrum using a score function J(:,:). Frequently, the score function
generates a theoretical spectrum for the given peptide and then
compares the observed and theoretical spectra to one another. The
program reports the candidate peptide that scores highest with
respect to the observed spectrum:
Figure 1. Overview of shotgun proteomics data production. (A) Schematic of a typical shotgun proteomics experiment. The three steps—(1)
cleaving proteins into peptides, (2) separation of peptides using liquid chromatography, and (3) tandem mass spectrometry analysis—are described
in the text. (B) A sample fragmentation spectrum, along with the peptide responsible for generating the spectrum.
doi:10.1371/journal.pcbi.1002296.g001
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Database search methods differ primarily in their choice of score
function.
An alternative to database search is de novo spectrum
identification, in which the ‘‘database’’ of candidate peptides
consists of the entire universe of possible amino acid sequences. A
variety of graph-based dynamic programming methods can
efficiently solve this problem, but in practice many spectra do
not contain sufficient information to uniquely identify the correct
peptide. Consequently, de novo identification methods generally
fail to provide as many correct identifications as database search
methods. Conversely, of course, de novo approaches are necessary
when a peptide database is unavailable—i.e., for analysis of
organims whose genomes have not yet been sequenced—or when
the user is interested in identifying novel protein isoforms or
polymporphisms.
Tag-based methods occupy an appealing middle ground be-
tween database search and de novo methods. Here, the basic idea
is to use de novo analysis to identify a collection of subpeptides
(‘‘tags’’) that are hypothesized to occur in the sequence, and then
extract candidates from a database that contain the tags. Tag-
based methods can be quite fast, and retain the ability to partially
identify spectra for which the corresponding peptide is not in the
database.
Finally, so-called library search methods identify spectra by
comparing them to a library of previously identified spectra. These
methods suffer a bit from a chicken-and-egg problem, in the sense
that you must first somehow identify the spectra that go into the
library. However, once you have successfully built such a library,
searching an observed spectrum against real spectra is likely to give
better results than searching against theoretical spectra. The
caveat is that you have to be sure that your library does not
contain false positives or chimeric spectra, i.e., spectra that were
generated by a heterogeneous population of two or more co-
eluting peptides.
Machine learning methods have been applied extensively to
the spectrum identification problem, primarily as post-processors
that discriminate between correct and incorrect identifications.
Using methods such as support vector machines [4], linear
discriminant analysis [5], or decision trees [6], these methods can
dramatically increase the percentage of spectra from a given
experiment that are confidently identified. Particularly powerful
are semi-supervised learning methods [7,8] that dynamically
adjust their ranking scheme on the basis of characteristics of a
given data set.
Protein Identification
Once the peptide responsible for generating each observed
spectrum has been identified, the downstream task of deciding
which proteins are present in the sample seems like it should
involve a straightforward process of aggregating evidence over all
the spectra associated with a given protein. Unfortunately, this task
is made much more difficult by the presence of so-called
degenerate peptides, i.e., peptides that occur in multiple proteins.
Protein identification algorithms have improved significantly
over the last decade. Early methods used simple heuristics to
identify high-confidence proteins that contain a specified number
of high-confidence peptide assignments [9]. A more sophisticated
version of this approach employs a parsimony argument and
attempts to find a minimal set of proteins that explain the observed
identified spectra [10]. The most widely used method is pseudo-
probabilistic, employing an expectation-maximization-like proce-
dure to apportion evidence from each degenerate peptide among
its corresponding parent proteins [11]. Other, related approaches
either handle peptide degeneracy in a similar, heuristic fashion
[12–14] or ignore the degeneracy entirely [15,16]. Only recently
have several groups proposed algorithms that directly solve the full
protein identification problem within a rigorous probabilistic
framework [17,18].
Computational and Statistical Challenges
Despite the almost dizzying array of existing methods for
identifying peptides and proteins from shotgun proteomics data
(reviewed in [19]), many significant analytical challenges remain.
Perhaps most ob-
vious is the need for algorithms that successfully identify proteins
that are not in the database, either because they are polymorphic
or because they contain post-translational modifications. The
difficulty here is two-fold: how to make the search efficient, and
how to successfully control the rate of false positive identifications,
especially in the case when a wide variety of polymorphisms or
modifications are allowed.
More fundamentally, the spectrum identification problem could
likely benefit from the application of a rich, generative model of
the peptide fragmentation process. Several such models have been
described in the spectrum identification literature [20,21], but
none take into account the relatively rich literature on peptide
fragmentation (reviewed in [22]).
A source of ongoing confusion and controversy in the field is the
assignment of statistical confidence estimates to spectrum, peptide,
or protein identifications. Varying protocols have been proposed,
based upon empirical null distributions created by searching the
spectra against a ‘‘decoy’’ database of shuffled or reversed peptide
sequences [23,24], upon procedures that involve fitting a para-
metric distribution to the empirical score distribution [25–27], or
upon score functions for which exact p-values can be calculated
under a simple zero-order Markov null model of peptides [28].
Critical assessment and comparison of many of these methods,
especially with respect to potential biases incurred during eva-
luation of new algorithsm, is lacking in the literature. Furthermore,
extending a statistic that is calculated with respect to individual
spectra up to the peptide and protein levels is a non-trivial and
relatively unexplored subject.
Historically, the development of tools for analyzing shotgun
proteomics data has occurred in a stepwise fashion. The result is
that small subtasks—assigning charge states to spectra, mapping
peptides to spectra, re-ranking and assigning statistical confidence
to spectrum identifications, and computing protein-level posteri-
ors—have been solved separately. Clearly, in the long run, this
piecemeal approach should be replaced by a joint model in which
all relevant aspects of the experiment are taken into account. Such
a joint model has the potential to model dependencies among
variables at the spectrum, peptide, and protein level that are
currently decoupled.
A perhaps equally challenging task is to convey the results of
such a rich model to the user in a useful fashion. With current
probabilistic protein identification tools, the standard approach of
reporting a ranked list of proteins is insufficient. Even when we
allow the list to contain groups of redundant proteins (i.e., protein
isoforms that are indistinguishable on the basis of the observed
spectra), crucial information about dependencies among the
protein identifications is lost. For example, it is difficult to convey
the information that, e.g., either protein A or protein B was
present in the sample, but probably not both.
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experimental design. Proteomics experiments can be expensive
and time consuming, yet most are being pursued without proper
care in minimizing batch or systematic effects. Furthermore, most
proteomics experiments are not powered correctly. Like gene
expression analyses previouly, proteomics practices could benefit
greatly from lessons learned in experimental design from classical
statistics.
Protein Quantification
The next logical step, after developing methods to identify the
proteins in a complex mixture, is to develop methods to quantify the
proteins. Quantification provides a more complete picture of the
molecular contents of the cell, and allows us to generate or test
specific hypotheses regarding the relationship between protein
abundance and fundamental cellular processes or disease states.
Existing methods for protein quantification fall into three
categories. Stable isotope labeling methods [29] perform relative
protein quantification by incorporating a distinct heavy isotope tag
to a sample to use as an internal standard. This labeled internal
standard is then mixed into one or more other samples, and the
relative signal intensity of the peptide measured by the mass
spectrometer is compared to the measured intensity of the same
peptide containing the heavy stable isotope label. This type of
approach is quite powerful but the isotopic labeling step imposes
significant overhead and limits the general applicability of these
methods. Spectral counting methods [30–33] rely on counting the
number of spectra that map to a given protein across multiple
experiments. Spectral counting methods are not very accurate,
because these methods fail to take into account the data-dependent
acquisition that leads to the selection of peptides for fragmenta-
tion. However, spectral counting is appealing because the required
counts are relatively easy to compute. Finally, peptide chromatographic
peak intensity methods [34–37] use the area under the precursor ion
peak as a proxy for peptide abundance. In contrast to spectral
counting, methods based on peak areas are potentially much more
accurate, but these methods require highly reproducible liquid
chromatography as well as accurate methods for chromatographic
alignment and identification of relevant spectral features.
Most of the mass spectrometry quantification literature focuses
on measuring the relative abundance of the same protein across
different samples. This allows, for example, comparing protein
expression across different patients, tissues, or developmental
stages. More difficult is estimating the relative abundance of two
proteins within the same sample. For this task, the most commonly
used, low-throughput approach is to calibrate the response of an
individual peptide in a targeted selective reaction monitoring
method (described in the next section). For large-scale quantifi-
cation of many proteins, a few methods use a standard shotgun
proteomics experiment, and either use a simple learning procedure
[30] or rely on the observation that the three most intense peptides
ionize similarly between proteins [38,39].
Targeted Proteomics
Many high-throughput proteomics experiments aim to identify
or quantify all proteins in a complex sample. In contrast, selected
reaction monitoring (SRM) experiments [40,41] seek to quantify a
smaller, specified set of proteins, e.g., a panel of biomarkers or
members of a pathway of interest.
In an SRM experiment, the mass spectrometer is set to monitor
the m/z values for a small number of peptides, as well as a specific
fragment ion for each peptide. Each m/z pair, corresponding to
the intact peptide and its fragment ion, is called a transition.
Monitoring a small number of transitions, rather than scanning
the entire m/z range, yields dramatically increased sensitivity
relative to conventional ‘‘full scan’’ techniques. The goal of SRM
is to select transitions that best detect the proteins of interest,
subject to the constraint that such experiments can monitor only
*1,000 transitions per run in an automated fashion [42]. Thus,
two complementary criteria must be optimized: (1) detect as many
proteins of interest as possible and (2) accurately estimate the
abundance of the monitored proteins.
Existing SRM pipelines typically focus on so-called proteotypic
peptides [43] that can be easily observed in a mass spectometry
experiment and that uniquely identify a specific protein. A variety
of methods exist for identifying proteotypic peptides, either based
on empirical rules [44,45] or machine learning methods
[43,46,47]. After identifying these peptides, SRM protocols
typically use them as independent protein identifiers [48], with
each peptide contributing equally to the evidence for that protein.
What is missing is a method to search for a panel of peptides that
jointly provide high quality quantification information about all of
the target proteins.
Outlook
Traditionally, most proteomics analysis has been carried out
using relatively inexpensive ion trap instruments, which offer fairly
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instruments, which achieve precision of ,10 ppm, were expensive
and hence more rare. However, with the introduction of Orbitrap
and improved quadrupole time-of-flight mass spectrometers [49],
high-resolution instruments have become much more common-
place. Corresponding analytical methods that fully exploit the
information available from high-resolution spectra have not used
these data to their full potential.
In a mass spectrometer, intact peptides are characterized in an
initial scan, followed by a series of secondary scans that cha-
racterize fragmented versions of the same peptides. The most
common means of fragmenting peptides between the two scans is
collision-induced dissociation, in which the charged peptides
collide with neutral molecules such as helium, nitrogen, or argon.
However, a variety of other fragmentation methods have been
developed, including electron-capture dissociation, electron-trans-
fer dissociation, and infrared multiphoton dissociation [50], and
these can provide fragmentation spectra with quite different
properties. More recently, some protocols have been developed to
alternate between different types of fragmentation methods, with
the aim of observing two complementary spectra representing
each peptide [51]. Most existing analysis pipelines are tuned to
handle one or two of the resulting types of spectra. Although some
search engines allow users to select which types of fragmentation
ions are included in the search, and some progress has been made
recently toward developing score functions that can be adapted to
various types of spectra [52], the field is still missing a generic
analysis platform that can be adapted automatically and in a
principled fashion to handle spectra produced by any given
fragmentation protocol.
An interesting consideration is that as the scan speeds of tandem
mass spectrometers increase, the difference between targeted and
discovery proteomics will become more and more blurred. As an
instrument becomes capable of collecting MS/MS spectra contin-
uously across the chromatographic time-scale on an increasingly
larger number of peptide precursors, the ‘‘m/z space’’ that remains
unsampled will become less significant. Approaches that improve
sampling by multiplexing the collection of fragmentation data are
promising, but require methods to deconvolve the resulting mixed
spectra. Such approaches fall under a general category known as
data-independent acquisition because they collect their fragmentation
data independently of whether a signal is observed within a par-
ticular precursor m/z window. Some initial attempts to interpret
these data have shoe-horned traditional proteomics analysis pipe-
lines to handle these data [53,54]. Other workflows that have been
developed specifically for these unique data have remained pro-
prietary and, thus, not attracted much effort from the academic
community to build and improve on these analyses.
One challenge that remains is enabling computational and
experimental scientists pursuing proteomics to interact effectively.
Frequently, experimentalists design new experiments using subop-
timal analysis tools because they do not have the skills or knowledge
to pursue alternatives. Likewise, computational scientists can ex-
pend a large amount of energy developing solutions to problems
that are not interesting to experimentalists. The challenge remains
how to get scientists from different disciplines that are based on
different cultures and who speak different scientific languages to
communicate and collaborate effectively. The RECOMB Satellite
Conference on Computational Proteomics is one attempt to solve
this problem. Speakers are brought from both the computational
and experimental backgrounds. This meeting provides a forum for
experimentalists to present problems that they are facing and for
computational scientists to present algorithmic and statistical
approaches that they have been developing. Ultimately, we need
more meetings that foster collaboration between disciplines.
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